publication venue for
- GERIATRIC ASSESSMENT CHANGES IN OLDER PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA UNDERGOING TREATMENT 2019
- The effect of age on referral to an oncologist and receipt of chemotherapy among small cell lung cancer patients in Ontario, Canada 2019
- Longitudinal changes in cognition in older individuals receiving lymphoma-directed therapy: A pilot feasibility study.. 16:102319. 2025
- Updates on myeloma in older adults: Conference summary from the 2024 International Myeloma Society annual meeting.. 16:102199. 2025
- SIOG2024-4-P-094 Impact of income on physical/emotional concerns and helpseeking by adult survivors of cancer (65+ years). 15:101975. 2024
- Perspectives on geriatric oncology research presented at the 2023 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology report. 15:101762-101762. 2024
- A structured oral chemotherapy teaching tool to improve adherence in adults with multiple myeloma: A pilot randomized controlled trial. 15:101735-101735. 2024
- Oncology nurses’ perceptions and practices regarding exercise discussion during clinic appointments. 14:S60-S61. 2023
- Risk of cancer-specific death among octogenarians with multiple myeloma: A population-based analysis. 14:101592-101592. 2023
- A pilot study of adherence to lenalidomide among older patients with multiple myeloma. 14:101560-101560. 2023
- Frailty and survival among veterans treated with abiraterone or enzalutamide for metastatic castration-resistant prostate cancer. 14:101520-101520. 2023
- What do hematology residents know about caring for older adults with cancer? A national survey of Canadian hematology residents' knowledge and interests. 13:1236-1240. 2022
- Exploring the relationships between income and emotional/practical concerns and help-seeking by older adult cancer survivors: A secondary analysis. 13:337-345. 2022
- Disparities in treatment patterns and outcomes among younger and older adults with newly diagnosed multiple myeloma: A population-based study. 12:508-514. 2021
- Transplant-ineligible newly diagnosed multiple myeloma: Current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper. 12:499-507. 2021
- Geriatric assessment and quality of life changes in older adults with newly diagnosed multiple myeloma undergoing treatment. 11:1279-1284. 2020
- Caring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspective. 11:1175-1181. 2020
- Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma. 11:764-768. 2020
- Perspectives from the Cancer and Aging Research Group: Caring for the vulnerable older patient with cancer and their caregivers during the COVID-19 crisis in the United States. 11:753-760. 2020
- Geriatric hematology research at the 2019 American Society of Hematology annual meeting: Young International Society of geriatric oncology perspective paper. 11:735-739. 2020
- Arti Hurria and the progress in integrating the geriatric assessment into oncology: Young International Society of Geriatric Oncology review paper. 11:203-211. 2020
- GOSAFE - Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery: early analysis on 977 patients. 11:244-255. 2020
- Autologous stem cell transplant in older patients (age ≥ 65) with newly diagnosed multiple myeloma: A systematic review and meta-analysis. 11:93-99. 2020
- The efficacy and toxicity of immune checkpoint inhibitors in a real-world older patient population. 10:411-414. 2019
- Quality of life and physical function in adults treated with intensive chemotherapy for acute myeloid leukemia improve over time independent of age. 6:262-271. 2015
- Tolerability and efficacy of docetaxel in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial. 5:119-126. 2014
- Does the hurria/CARG tool or VES-13 predict grade 3+ toxicities in men undergoing chemotherapy for metastatic prostate cancer?. 4:s37. 2013